Development and evaluation of orally disintegrating tablets containing the mosapride resin complex
Sign Up to like & getrecommendations! Published in 2018 at "Acta Pharmaceutica"
DOI: 10.2478/acph-2018-0017
Abstract: Abstract The purpose of this study was to prepare a mosapride citrate-resin (Amberlite® IRP 88) complex and orally fast-disintegrating tablets of the resin complex. The resinate complex of mosapride-Amberlite® IRP 88, mass ratio 2:1, was… read more here.
Keywords: disintegrating tablets; orally disintegrating; tablets containing; resin complex ... See more keywords